ClinicalTrials.gg
Active, not recruitingNCT07935772Updated Nov 13, 2026

The Effect of Kinesiology Taping Applied to the Diaphragm Muscle on Respiratory Functions, Balance, Functional Capacity and Quality of Life in Stroke Patients

An interventional study of Kinesio Tex Taping and breathing exercise arm in Hemiplegia, sponsored by Bezmialem Vakif University. Active, not recruiting at 1 site in Turkey (Türkiye). Open to participants aged 18 Years to 90 Years. Per ClinicalTrials.gov, last updated 2026-11-13.

Sponsored by Bezmialem Vakif University · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Registered 8 months after the study started (first participant enrolled Feb 2026, registered Oct 2026).
Updated Nov 13, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Randomized
Ages
18 Years to 90 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 108 studies in Hemiplegia with a site in Turkey — 22 open to participants now, 27 under way, none of them phase 3. Hemiplegia · Turkey.

Enrollment
48th of 76
30 · median 40
Started
2026
with 14 others
No phase
73 of 108
13 open now
Primary completion
2026-11
later than 20 of 26 live
Registered
108th of 108
by date
Lead sponsor
4 of 108
Bezmialem Vakif University

Among the 108 studies in Hemiplegia with a site in Turkey, this one is the 48th largest by enrollment of the 76 interventional ones that give a count, is one of 15 that started in 2026, is one of 73 with no phase, reaches primary completion later than 20 of the 26 other live ones, and was the 108th registered.

Hemiplegia

450 studies on the registry are indexed under Hemiplegia; 92 are open to participants now.

Browse Hemiplegia studies →

Open to participants now

22 of the 108 studies in Hemiplegia with a site in Turkey are open now. Recruiting first, the newest first:

17 more — sign in →

All 22 open studies →

A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →

Who these studies take

Of the 59 Hemiplegia studies recruiting now, 16 (27%) set no upper age limit and 31 (53%) stop at 75 or younger; 9 take children under 18; 7 take healthy volunteers.

This study: 18 Years to 90 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 108 studies in Hemiplegia with a site in Turkey, or all of them as a file.
02

Study summary

The aim of this study is to investigate the effects of Kinesio Taping applied to the diaphragm muscle on respiratory functions, balance, functional capacity, and quality of life in stroke patients.

03

Conditions studied

  • Hemiplegia

Browse trials for

Keywords

  • Hemiplegia
  • Kinesio Tex Taping
  • Diaphragm
  • Respiration
  • Balance
  • Postural control
04

Who can participate

Ages eligible
18 Years to 90 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Having a radiologically confirmed diagnosis of cerebrovascular disease
  • Being medically stable
  • Being aged 18 years or older
  • Being literate
  • Presence of unilateral hemiplegia
  • Having experienced a first-ever stroke
  • Having a (MMSE) score greater than 24
  • Having no prior history of cardiovascular and/or pulmonary diseases
  • Absence of facial palsy (facial paralysis)
  • Having a lower extremity Brunnstrom stage of at least 3

Exclusion criteria

Exclusion Criteria:

  • Enteral feeding via PEG
  • Having undergone surgery within the past 6 months
  • Pregnancy
  • Having broken, irritated, or damaged skin at the application site
  • Presence of active thrombosis
  • Having a diagnosis of heart failure
  • Presence of uncontrolled hypertension or cardiac disease
  • Having a history of epileptic seizures
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

MMSE and MoCA

Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
30 participants (actual)

Study arms

  • Experimental
    Kinesio Tex Taping and breathing exercise arm

    General physiotherapy sessions are administered twice weekly for 8 weeks. Following each general physiotherapy session, Kinesiology Taping is applied over the diaphragm muscle, followed by respiratory exercises. Patients are asked to perform the breathing exercises twice a day (morning and evening), 5 days a week, while the tape is in place. Home-based breathing exercises are monitored via daily log sheets provided to the patients. These log sheets are checked at each encounter with the patient. The tape is renewed every three days.

    Device: Kinesio Tex Taping

  • Active comparator
    breathing exercise arm

    General physiotherapy sessions are administered twice weekly for 8 weeks. Following each general physiotherapy session, sham Kinesiology Taping is applied to the chest area, followed by respiratory exercises. Patients are asked to perform the breathing exercises twice a day (morning and evening), 5 days a week, while the tape is in place. Home-based breathing exercises are monitored via daily log sheets provided to the patients. These log sheets are checked at each encounter with the patient. The tape is renewed every three days.

    Device: breathing exercise arm

Interventions

  • DeviceKinesio Tex Taping

    General physiotherapy sessions are administered twice weekly for 8 weeks. Following each general physiotherapy session, Kinesiology Taping is applied over the diaphragm muscle, followed by respiratory exercises. Patients are asked to perform the breathing exercises twice a day (morning and evening), 5 days a week, while the tape is in place. Home-based breathing exercises are monitored via daily log sheets provided to the patients. These log sheets are checked at each encounter with the patient. The tape is renewed every three days.

  • Devicebreathing exercise arm

    General physiotherapy sessions are administered twice weekly for 8 weeks. Following each general physiotherapy session, sham Kinesiology Taping is applied to the chest area, followed by respiratory exercises. Patients are asked to perform the breathing exercises twice a day (morning and evening), 5 days a week, while the tape is in place. Home-based breathing exercises are monitored via daily log sheets provided to the patients. These log sheets are checked at each encounter with the patient. The tape is renewed every three days.

06

What researchers measure

Primary outcomes

  1. Change in Forced Vital Capacity (FVC)

    FVC will be measured using a spirometer according to ATS/ERS standards. Unit of Measure: Liters (or Percentage of predicted)

    Time frame: 8 weeks

  2. Change in Forced Expiratory Volume in 1 Second (FEV1)

    FEV1 will be measured using a spirometer according to ATS/ERS standards. Unit of Measure: Liters (or Percentage of predicted)

    Time frame: 8 weeks

  3. Change in Ratio of Forced Expiratory Volume in 1 Second to Forced Vital Capacity (FEV1/FVC)

    The ratio of FEV1 to FVC will be assessed using a digital spirometer in accordance with ATS/ERS standards. This ratio is calculated by dividing FEV1 (in liters) by FVC (in liters) and expressing it as a percentage to evaluate airway obstruction. Higher percentages indicate better airflow and absence of obstructive airway limitation (normal reference value is typically above 70%). Unit of Measure: Percentage (or %)

    Time frame: 8 weeks

  4. Change in Peak Expiratory Flow (PEF)

    Peak expiratory flow will be assessed using a digital spirometer \[veya peak flow meter\] in accordance with ATS/ERS standards. The test will be performed in a seated position, and the highest value among three acceptable and reproducible maneuvers will be recorded. Higher values indicate better expiratory airflow and expiratory muscle function. Unit of Measure: Liters per minute (L/min) (or Percentage of predicted)

    Time frame: 8 weeks

  5. Change in Forced Expiratory Flow at 25% to 75% of Forced Vital Capacity (FEF25-75)

    Forced expiratory flow at 25-75% of FVC will be assessed using a digital spirometer in accordance with ATS/ERS standards. This parameter reflects the average flow rate during the middle portion of the forced vital capacity maneuver and evaluates small airway function. Higher values indicate better peripheral airway patency and function. Liters per second (L/s) (or Percentage of predicted)

    Time frame: 8 weeks

  6. Change in Maximal Inspiratory Pressure (MIP)

    MIP will be evaluated using a digital mouth pressure meter to determine inspiratory muscle strength. Unit of Measure: cmH2O

    Time frame: 8 weeks

  7. Change in Maximal Expiratory Pressure (MEP)

    Maximal expiratory pressure will be evaluated using a digital mouth pressure meter (or respiratory pressure meter) in accordance with ATS/ERS guidelines to assess expiratory muscle strength. The participant will perform a maximal forced expiration against an occluded airway starting from total lung capacity. The highest value obtained from three acceptable and reproducible maneuvers will be recorded. Higher values indicate greater expiratory muscle strength. Unit of Measure: cmH2O

    Time frame: 8 weeks

  8. Change in Postural Stability - Overall Stability Index (OSI) score

    Postural control will be evaluated using the Biodex Balance System. The Postural Stability Test will be conducted with the participant standing barefoot on the platform.The Overall Stability Index measures the angular deviation of the platform's motion from horizontal across all directions. Scores range from 0 to approximately 10 degrees, where lower scores indicate better postural stability and balance control, and higher scores indicate greater displacement and poorer balance. Unit of Measure: Degrees (or Score)

    Time frame: 8 weeks

  9. Change in Limits of Stability (LOS) Overall Directional Control Score

    Dynamic balance and voluntary postural control will be evaluated using the Limits of Stability test on the Biodex Balance System. Participants stand on the platform and intentionally shift their center of gravity to move an on-screen cursor toward eight directional targets without moving their feet. The test provides an overall directional control score calculated as a percentage, ranging from 0% to 100%. Higher scores indicate better directional control, faster task completion, and greater dynamic postural stability. Percentage (%) (or Seconds)

    Time frame: 8 weeks

  10. Change in Fall Risk Index Score on the Biodex Balance System

    Fall risk will be assessed using the Fall Risk Test protocol on the Biodex Balance System. The test evaluates dynamic postural control on an unstable platform across standardized dynamic stability levels. The resulting Fall Risk Index reflects the degree of platform displacement from the horizontal plane (ranging from 0 to approximately 10 degrees). Lower scores indicate better postural stability and a lower risk of falls, whereas higher scores indicate greater postural sway and an increased risk of falling compared to age-matched normative data.

    Time frame: 8 weeks

Secondary outcomes

  1. Change in 2-Minute Walk Distance (2MWD)

    Functional capacity will be evaluated using the 2-Minute Walk Test according to standard guidelines. Unit of Measure: Meters

    Time frame: 8 weeks

  2. Change in Stroke-Specific Quality of Life Scale (SSQOL) score

    Quality of life will be assessed using the Stroke Specific Quality of Life Scale. Scores range from 49 to 245, where higher scores indicate a better quality of life.

    Time frame: 8 weeks

  3. Change in Modified Barthel Index (MBI) Total Score

    Functional independence in activities of daily living will be evaluated using the Modified Barthel Index. The scale assesses 10 core activities (personal hygiene, bathing, feeding, toileting, stair climbing, dressing, bowel control, bladder control, ambulation/wheelchair mobility, and chair/bed transfers). Total scores range from 0 to 100, where higher scores indicate greater functional independence and lower scores indicate higher dependence on assistance (0-24: total dependence, 25-49: severe dependence, 50-74: moderate dependence, 75-90: mild dependence, 91-99: minimal dependence, 100: independent).

    Time frame: 8 weeks

  4. Change in Fatigue Severity Scale (FSS) Mean Score

    Fatigue severity and its impact on daily functioning will be evaluated using the Fatigue Severity Scale. The scale consists of 9 items scored on a 7-point Likert scale ranging from 1 ("strongly disagree") to 7 ("strongly agree"). The total score is calculated as the mean of all 9 items (ranging from 1 to 7 or ranging from 9 to 63)

    Time frame: 8 weeks

  5. Change in Time to Complete the 5-Times Sit-to-Stand Test

    Participants sit on an armless chair of standard height (approximately 43-45 cm) with their arms crossed over their chest and their back touching the backrest. Upon the "Go" command, the participant stands up completely and sits down five consecutive times as quickly and safely as possible. The time taken to complete the five full repetitions is measured with a digital stopwatch. Shorter completion times indicate better lower extremity muscle performance and functional mobility, whereas longer completion times indicate greater functional impairment and higher fall risk. Unit of Measure:Seconds

    Time frame: 8 weeks

07

Study locations

1 site
08

References and documents

Publications

  • Elsherbini DMA, Eladl HM, Allam NM, Abulfaraj M, El-Sherbiny M, Nosseir N, Maghrabi A, Jamal W, Abdelrahman MMA, Eladl MA. Efficacy of combined Kinesio-taping with chest physiotherapy program on pain, pulmonary function, respiratory muscle strength and quality of life after mastectomy: a randomized controlled trial. Front Med (Lausanne). 2026 Jan 22;12:1664210. doi: 10.3389/fmed.2025.1664210. eCollection 2025. PubMed 41657582 ↗
  • Schvambach M, Isoppo KDS. Immediate effects of Kinesio Taping (R) on respiratory parameters in healthy individuals. J Bodyw Mov Ther. 2024 Oct;40:1153-1157. doi: 10.1016/j.jbmt.2024.07.030. Epub 2024 Jul 11. PubMed 39593427 ↗
  • Wang JS, Cho KH, Park SJ. The immediate effect of diaphragm taping with breathing exercise on muscle tone and stiffness of respiratory muscles and SpO2 in stroke patient. J Phys Ther Sci. 2017 Jun;29(6):970-973. doi: 10.1589/jpts.29.970. Epub 2017 Jun 7. PubMed 28626302 ↗

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: Yes — first attack experienced hemiplegic patient

Supporting information: Study protocol, Statistical analysis plan, Informed consent form, Clinical study report, Analytic code

Time frame: NOVEMBER 25 2026 - Indefinite

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Feb 2026 (actual). Primary completion is estimated for Nov 2026, 9 months after the start.

Of 226 non-industry interventional studies with no phase under Hemiplegia, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 27. This study's planned 9 months is below that.

Counting every sponsor, half of 231 studies reached it within 12 months; a quarter within 5 and three quarters within 27.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 30, 2026
First posted
Nov 13, 2026
StartActual
Feb 1, 2026
Primary completionEst.
Nov 20, 2026
CompletionEst.
Nov 25, 2026
Last update
Nov 13, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 13, 2026
Show all 1 update
  1. Nov 13, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07935772
Responsible party
Süheda hasözdemir (Principal Investigator, Bezmialem Vakif University) — Principal investigator
First posted
Nov 13, 2026
Start date
Feb 1, 2026
Primary completion
Nov 20, 2026 (estimated)
Completion
Nov 25, 2026 (estimated)
Last update
Nov 13, 2026

Study contacts

Semiramis Özyılmaz
study director · Bezmialem Univercity

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion